What Comes Next ?Predictably as the good news fades the volume has dropped off and we begin to see the erosion of the share price. I think us longs are breathing a sigh of relief that the company will have the working capital not only to survive but over time bring their assets to market. Now it is time to take this to the next level. Firstly this will require a detailed timeline of the Dermal Injector's path to market. Dermal Injector distribution agreements for Europe, Canada, South America etc.. Update on Yofoto's Phase 2 Skin and Tendon Trials. New partnerships in Japan for further Skin and Tendon Trials. Lastly we need to finally make peace with Shiseido. If not, what is the plan for RCH-01.
Let's start with the Dermal Injector timeline. Just this first step will see the share price blast through $.40 on it's way to $1.00.